Role of KRas Status in Patients With Metastatic Colorectal Cancer Receiving First-line Chemotherapy Plus Bevacizumab - a TTD Spanish Group Cooperative Study

dc.contributor.author	Reboredo Lopez, Margarita
dc.date.accessioned	2017-06-07T07:07:32Z
dc.date.available	2017-06-07T07:07:32Z
dc.date.issued	2011
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/20.500.11940/2874
dc.language.iso	eng
dc.title	Role of KRas Status in Patients With Metastatic Colorectal Cancer Receiving First-line Chemotherapy Plus Bevacizumab - a TTD Spanish Group Cooperative Study
dc.type	Publicación de congreso
dc.authorsophos	Garcia, E. D. R.
dc.authorsophos	Gomez, A.
dc.authorsophos	Yuste, A.
dc.authorsophos	Puente, J.
dc.authorsophos	Lopez-Lopez, C.
dc.authorsophos	Safont, M. J.
dc.authorsophos	Layos, L.
dc.authorsophos	Reboredo, M.
dc.authorsophos	Benavides, M.
dc.authorsophos	Aranda, E.
dc.identifier.isi	295752801374
dc.identifier.sophos	9146
dc.issue.number	Suplemento: 1
dc.journal.title	EUROPEAN JOURNAL OF CANCER
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.page.initial	S391
dc.page.final	S392
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	47

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.